Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-23-015636

Options or other derivatives

  • Chief Financial Officer acquired 632,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Silver Brian M. Chief Financial Officer 2023-06-13 Grant or award · Stock Option (Right to Buy) +632,500 632,500 D
Loading xslF345X04/doc4.xml…